CAT and central nervous system cancer: In fact, both C6 GB cells and normal astrocytes were treated with PPAR-α and PPAR-γ agonists, showing a significant increase in catalase expression only in normal astrocytes, while, on the contrary, they failed to increase catalase expression in glioma cells.